Literature DB >> 20084018

Oxidative stress in the progression of Alzheimer disease in the frontal cortex.

Mubeen A Ansari1, Stephen W Scheff.   

Abstract

We investigated oxidative stress in human postmortem frontal cortexfrom individuals characterized as mild cognitive impairment (n= 8), mild/moderate Alzheimer disease (n = 4), and late-stage Alzheimer disease (n = 9). Samples from subjects with no cognitive impairment (n = 10) that were age- and postmortem interval-matched with these cases were used as controls. The short postmortem intervalbrain samples were processed for postmitochondrial supernatant, nonsynaptic mitochondria, and synaptosome fractions. Samples were analyzed for several antioxidants (glutathione, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, glucose-6-phosphate dehydrogenase, superoxide dismutase, catalase) and the oxidative marker, thiobarbituric acid reactive substances. The tissue was also analyzed for possible changes in protein damage using neurochemical markers for protein carbonyls, 3-nitrotyrosine, 4-hydroxynonenal, andacrolein. All 3 neuropil fractions (postmitochondrial supernatant, mitochondrial, and synaptosomal) demonstrated significant disease-dependent increases in oxidative markers. The highest changes were observed in the synaptosomal fraction. Both mitochondrial and synaptosomal fractions had significant declines in antioxidants (glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase). Levels of oxidative markers significantly correlated with Mini-Mental Status Examination scores. Oxidative stress was more localized to the synapses, with levels increasing in a disease-dependent fashion. These correlations implicate an involvement of oxidative stress in Alzheimer disease-related synaptic loss.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20084018      PMCID: PMC2826839          DOI: 10.1097/NEN.0b013e3181cb5af4

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  93 in total

1.  Depletion of cytosolic GSH decreases the ATP levels and viability of synaptosomes from aged mice but not from young mice.

Authors:  M Martínez; M L Ferrándiz; A Díez; J Miquel
Journal:  Mech Ageing Dev       Date:  1995-09-29       Impact factor: 5.432

2.  Widespread peroxynitrite-mediated damage in Alzheimer's disease.

Authors:  M A Smith; P L Richey Harris; L M Sayre; J S Beckman; G Perry
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

3.  Brain monoaminergic and neuropeptidergic variations in human aging.

Authors:  B Arranz; K Blennow; R Ekman; A Eriksson; J E Månsson; J Marcusson
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

Authors:  M A Lovell; W D Ehmann; S M Butler; W R Markesbery
Journal:  Neurology       Date:  1995-08       Impact factor: 9.910

5.  Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation.

Authors:  K Hensley; N Hall; R Subramaniam; P Cole; M Harris; M Aksenov; M Aksenova; S P Gabbita; J F Wu; J M Carney
Journal:  J Neurochem       Date:  1995-11       Impact factor: 5.372

6.  The two catalytic components of the 2-oxoglutarate dehydrogenase complex in rat cerebral synaptic and nonsynaptic mitochondria: comparison of the response to in vitro treatment with ammonia, hyperammonemia, and hepatic encephalopathy.

Authors:  L Faff-Michalak; J Albrecht
Journal:  Neurochem Res       Date:  1993-02       Impact factor: 3.996

7.  Evidence of neuronal oxidative damage in Alzheimer's disease.

Authors:  P F Good; P Werner; A Hsu; C W Olanow; D P Perl
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

8.  Evidence of an oxidative challenge in the Alzheimer's brain.

Authors:  L Balazs; M Leon
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

9.  Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease.

Authors:  A M Palmer; M A Burns
Journal:  Brain Res       Date:  1994-05-09       Impact factor: 3.252

Review 10.  Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system.

Authors:  G Benzi; A Moretti
Journal:  Free Radic Biol Med       Date:  1995-07       Impact factor: 7.376

View more
  169 in total

1.  A calorie-restricted diet decreases brain iron accumulation and preserves motor performance in old rhesus monkeys.

Authors:  Erik K Kastman; Auriel A Willette; Christopher L Coe; Barbara B Bendlin; Kris J Kosmatka; Donald G McLaren; Guofan Xu; Elisa Canu; Aaron S Field; Andrew L Alexander; Mary Lou Voytko; T Mark Beasley; Ricki J Colman; Richard H Weindruch; Sterling C Johnson
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.

Authors:  Kazuma Murakami; Nakaba Murata; Yoshihiro Noda; Shoichi Tahara; Takao Kaneko; Noriaki Kinoshita; Hiroyuki Hatsuta; Shigeo Murayama; Kevin J Barnham; Kazuhiro Irie; Takuji Shirasawa; Takahiko Shimizu
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

3.  The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption.

Authors:  Justin Legleiter; John D Fryer; David M Holtzman; Andtomasz Kowalewski
Journal:  ACS Chem Neurosci       Date:  2011-10-19       Impact factor: 4.418

Review 4.  Metals, oxidative stress and neurodegenerative disorders.

Authors:  Klaudia Jomova; Dagmar Vondrakova; Michael Lawson; Marian Valko
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

Review 5.  Actin dynamics and cofilin-actin rods in alzheimer disease.

Authors:  James R Bamburg; Barbara W Bernstein
Journal:  Cytoskeleton (Hoboken)       Date:  2016-03-01

Review 6.  Mechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylation.

Authors:  Elizabeth A Sabens Liedhegner; Xing-Huang Gao; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2012-01-06       Impact factor: 8.401

7.  Measurement of human skeletal muscle oxidative capacity by 31P-MR spectroscopy: a cross-validation with in vitro measurements.

Authors:  Ian R Lanza; Sumit Bhagra; K Sreekumaran Nair; John D Port
Journal:  J Magn Reson Imaging       Date:  2011-11       Impact factor: 4.813

8.  Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats.

Authors:  Olayemi Joseph Olajide; Nnaemeka Tobechukwu Asogwa; Blessing Oluwapelumi Moses; Christiana Bidemi Oyegbola
Journal:  Metab Brain Dis       Date:  2017-04-13       Impact factor: 3.584

9.  Can urinary excretion rate of 8-isoprostrane and malonaldehyde predict postoperative cognitive dysfunction in aging?

Authors:  Qinghao Cheng; Jiawan Wang; Anshi Wu; Rujin Zhang; Lei Li; Yun Yue
Journal:  Neurol Sci       Date:  2013-02-05       Impact factor: 3.307

Review 10.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.